4-(dichloro(tosyl)methyl)-2-methyl-5-nitrothiazole

ID: ALA5285115

Max Phase: Preclinical

Molecular Formula: C12H10Cl2N2O4S2

Molecular Weight: 381.26

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)C(Cl)(Cl)c2nc(C)sc2[N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C12H10Cl2N2O4S2/c1-7-3-5-9(6-4-7)22(19,20)12(13,14)10-11(16(17)18)21-8(2)15-10/h3-6H,1-2H3

Standard InChI Key:  JMCDNVCJIBVMHD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 23  0  0  0  0  0  0  0  0999 V2000
   -2.3789    2.6822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7308   -0.1744    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7308   -0.9994    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4466   -0.5876    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.0941    0.6506    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    0.8099    0.2388    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.5361   -1.8854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7496   -2.6822    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1195   -1.3020    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9284   -2.1639    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3789   -1.9066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3319   -0.8888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7290    1.2576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1433    0.5401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9684    0.5401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3789    1.2530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9663    1.9677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1455    1.9677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0941   -0.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5066   -0.8888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2607   -1.6718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5821   -1.6931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  2  0
  2  4  2  0
  7  8  2  0
  7  9  1  0
 14 13  1  0
  2 14  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 17  1  1  0
 18 17  1  0
 13 18  2  0
 19  2  1  0
 19  5  1  0
 19  6  1  0
 20 19  1  0
 20 12  1  0
 20 21  2  0
  7 21  1  0
 21 10  1  0
 22 10  1  0
 22 11  1  0
 12 22  2  0
M  CHG  2   7   1   9  -1
M  END

Alternative Forms

  1. Parent:

    ALA5285115

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Colon cell line (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.26Molecular Weight (Monoisotopic): 379.9459AlogP: 3.73#Rotatable Bonds: 4
Polar Surface Area: 90.17Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.42CX LogD: 4.42
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.46Np Likeness Score: -1.39

References

1. Sharma PC, Bansal KK, Sharma A, Sharma D, Deep A..  (2020)  Thiazole-containing compounds as therapeutic targets for cancer therapy.,  188  [PMID:31926469] [10.1016/j.ejmech.2019.112016]

Source